• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARROW INTERNATIONAL ARROWGARD CVC BLUE PLUS; CATHETER PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARROW INTERNATIONAL ARROWGARD CVC BLUE PLUS; CATHETER PERCUTANEOUS Back to Search Results
Lot Number 13F17HO327
Health Effect - Clinical Code No Information (3190)
Date of Event 03/07/2018
Type of Reportable Event Serious Injury
Event or Problem Description
While inserting a central line the guidewire unraveled arrowgard blue plus multi-lumen cvs extreme kit #7 french /3 lumen/20 cm 0.032 inch spring wire lot # 13f17ho327 with ref # ak-45703-ax.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARROWGARD CVC BLUE PLUS
Common Device Name
CATHETER PERCUTANEOUS
Manufacturer (Section D)
ARROW INTERNATIONAL
MDR Report Key7340952
Report NumberMW5075879
Device Sequence Number1556344
Product Code DQY
UDI-Device Identifier10801902119169
UDI-Public0110801902119169
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Device Explanted Year2018
Reporter Type Voluntary
Initial Reporter Occupation Nurse
Type of Report Initial
Report Date (Section B) 03/13/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/28/2019
Device Lot Number13F17HO327
Was Device Available for Evaluation? Yes
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date03/14/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age65 YR
Patient Weight75
-
-